The Cultured AFB (Acid-Fast Bacillus) Antitubercular DST (Drug Susceptibility Testing) Rapid 15 Drugs Panel Test is an advanced diagnostic tool used to evaluate the susceptibility of the tuberculosis (TB) bacteria to a panel of 15 different antitubercular drugs. This test is crucial for tailoring the most effective treatment plan for individuals diagnosed with TB, especially in cases of multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB (XDR-TB).
Performed at DNA Labs UAE, a state-of-the-art facility known for its comprehensive range of diagnostic services, this test utilizes cultured TB bacteria from the patient's sample. By exposing these cultured bacteria to the 15 antitubercular drugs, the test identifies which medications the bacteria are resistant to, thereby guiding healthcare providers in selecting the most appropriate and effective treatment regimen.
The cost of the Cultured AFB Antitubercular DST Rapid 15 Drugs Panel Test at DNA Labs UAE is 3930 AED. Considering the critical information it provides for managing and treating TB effectively, this test represents a valuable investment in the health and well-being of patients facing this challenging disease.
Hypersensitivity Pneumonitis (HP) Screen Test is a diagnostic tool used to identify Hypersensitivity Pneumonitis, a complex condition characterized by inflammation of the lungs due to an allergic reaction to inhaled dust, fungus, molds, or chemicals. This condition, if left untreated, can lead to severe lung disease. The test aims to detect specific antibodies or markers in the blood that are indicative of an immune response to the suspected allergens.
Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the HP Screen Test utilizes advanced laboratory techniques to ensure accurate and reliable results. The test is priced at 3930 AED, reflecting the comprehensive approach and the sophisticated technology employed in the analysis. Patients undergoing this test at DNA Labs UAE can expect professional service and detailed results, which are crucial for the timely and effective management of Hypersensitivity Pneumonitis.
The HLA Pre-Transplant Workup Sensitized Recipient Panel 3 Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to evaluate the compatibility between organ transplant donors and recipients. This test plays a crucial role in the pre-transplant assessment phase, particularly for recipients who are considered sensitized due to previous exposure to foreign human leukocyte antigens (HLA) through transfusions, pregnancies, or prior transplants. Sensitization can significantly impact the success of organ transplants, making this test vital for identifying potential risks and ensuring the compatibility of the donor organ.
By analyzing the recipient's immune response to a range of HLA antigens, the test aims to detect the presence of antibodies that could lead to organ rejection. This helps in the selection of a compatible donor, thereby increasing the chances of transplant success and patient survival. The cost of the HLA Pre-Transplant Workup Sensitized Recipient Panel 3 Test at DNA Labs UAE is 4630 AED, reflecting the comprehensive and sophisticated nature of the analysis. This investment is crucial for sensitized recipients to ensure the best possible outcomes in their transplant journey.
The "Cultured AFB Antitubercular DST Rapid 16 Drugs Panel Test" is a comprehensive diagnostic examination conducted to assess the resistance of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis (TB), against a panel of 16 antitubercular drugs. This test is crucial for tailoring the most effective treatment plan for TB patients, especially in cases where drug resistance is suspected. By evaluating the bacterium's susceptibility to a wide range of medications, healthcare providers can make informed decisions on the best course of treatment, thus improving patient outcomes and helping to combat the global challenge of multidrug-resistant TB.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic techniques and reliable results, this test involves culturing the bacteria from a patient's sample to determine the specific drugs to which the bacteria show resistance. The cost of the test is 4610 AED, reflecting the comprehensive nature of the analysis and the sophisticated technology used to obtain accurate, rapid results. This test is an invaluable tool in the fight against tuberculosis, ensuring that patients receive the most effective treatment in a timely manner.
The Interleukin-2 Receptor Alpha Chain (IL-2R) Test is a diagnostic procedure aimed at measuring the levels of the alpha chain of the interleukin-2 receptor in the blood. This test is pivotal in assessing the activation state of T lymphocytes, a type of white blood cell integral to the body's immune response. Elevated levels of IL-2R can indicate an active immune response, potentially signifying autoimmune disorders, transplant rejection, or certain types of cancer, such as lymphoma.
Conducted at DNA Labs UAE, a leading facility known for its advanced diagnostic services, the IL-2R Test provides critical insights into a patient's immune system functionality. The test is priced at 4550 AED, reflecting the sophisticated technology and expertise required to accurately measure this specific marker. For patients undergoing this test, it offers valuable information that can guide treatment decisions and monitor the effectiveness of immunotherapy or other treatments affecting the immune system.
The Liquid Biopsy cfDNA EGFR Test is a cutting-edge diagnostic procedure available at DNA Labs UAE, designed to detect the presence of specific mutations in the epidermal growth factor receptor (EGFR) gene within circulating free DNA (cfDNA) found in a patient's blood. This non-invasive test is particularly vital for individuals with non-small cell lung cancer (NSCLC), as it helps in identifying mutations in the EGFR gene that may influence treatment choices and outcomes. By analyzing cfDNA, the test can provide crucial information without the need for a traditional tissue biopsy, which can be invasive and challenging in certain cases.
The process involves a simple blood draw, after which the sample is analyzed using advanced genomic sequencing technologies to detect EGFR gene mutations. This approach allows for real-time monitoring of tumor dynamics, detection of resistance mutations that may develop during treatment, and aids in the selection of targeted therapies that are more likely to be effective based on the genetic makeup of the cancer.
Priced at 4510 AED, the Liquid Biopsy cfDNA EGFR Test offered by DNA Labs UAE represents a significant advancement in personalized cancer care, offering a less invasive, quicker, and often more feasible option for obtaining vital genetic information that can guide treatment decisions and improve patient outcomes.
The B-Cell Rearrangement Detection Test is a sophisticated diagnostic procedure utilized to identify rearrangements in the genes associated with B-cells, a type of white blood cell. This test is pivotal in diagnosing and monitoring various hematological disorders and cancers, such as lymphomas and leukemias, where B-cell abnormalities play a critical role. By detecting unique genetic signatures through rearrangement patterns, healthcare providers can tailor treatment strategies more effectively, monitor disease progression, and predict patient outcomes with greater accuracy.
At DNA Labs UAE, this test is offered at a cost of 3300 AED. DNA Labs UAE is renowned for its state-of-the-art facilities and adherence to stringent quality control measures, ensuring that patients and healthcare providers receive reliable and precise test results. The lab employs cutting-edge technology and methodologies to detect B-cell rearrangements, providing critical insights into the genetic underpinnings of hematological diseases. This test represents a vital tool in the arsenal of diagnostic options, facilitating early detection and the implementation of targeted therapies to improve patient care and outcomes.
The "HLA Pre-Transplant Workup Non-Sensitized Recipient Panel 1 Test" is a crucial laboratory examination performed at DNA Labs UAE, priced at 4490 AED. This test is specifically designed for individuals awaiting organ transplantation who are considered non-sensitized recipients, meaning they have not previously developed antibodies against potential donor antigens. The primary goal of this test is to assess the human leukocyte antigen (HLA) compatibility between the donor and the recipient to minimize the risk of transplant rejection.
HLA matching is a critical factor in the success of organ transplants, including kidney, liver, heart, and bone marrow transplants. A close HLA match between the donor and recipient can significantly improve transplant outcomes and increase the longevity of the transplanted organ. The panel includes a series of tests that analyze the recipient's HLA type and screen for any pre-existing antibodies that might lead to complications post-transplant.
Conducted in the state-of-the-art facilities of DNA Labs UAE, this test employs advanced techniques to ensure precise and reliable results. The cost of 4490 AED reflects the comprehensive nature of the analysis and the sophisticated technology used. For patients in the pre-transplant phase, this test is an essential step in the preparation process, helping healthcare providers to make informed decisions regarding donor selection and transplant timing, ultimately aiming to achieve the best possible patient outcomes.
The "AML Panel Cytogenetics and FISH AMLETO Inv16 PML-RARA MLL Test" is a comprehensive diagnostic assessment designed to identify specific genetic abnormalities associated with Acute Myeloid Leukemia (AML). This test is pivotal in the diagnosis and management of AML, a type of cancer that affects the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells. The panel includes cytogenetic analysis and Fluorescence In Situ Hybridization (FISH) to detect chromosomal alterations such as Inv16, PML-RARA, and MLL rearrangements, which are crucial for determining prognosis, guiding treatment decisions, and monitoring response to therapy.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced diagnostic services, this test is priced at 4450 AED. The laboratory utilizes cutting-edge technology and adheres to stringent quality control measures to ensure accurate and reliable results. By identifying specific genetic mutations and chromosomal changes, the AML Panel Cytogenetics and FISH test provides essential information that helps clinicians tailor treatment strategies to the individual needs of their patients, ultimately aiming to improve outcomes in those affected by Acute Myeloid Leukemia.
Beta Thalassemia is a genetic blood disorder characterized by the reduction in the production of hemoglobin, which can lead to a range of health issues, including anemia, fatigue, and more severe complications if left untreated. The disorder is inherited, making genetic testing crucial for couples who have a family history of thalassemia or are carriers of the gene mutation.
The "Beta Thalassemia-HBB Full Gene Analysis Couple and Prenatal Trio Analysis Test" is a comprehensive genetic screening offered by DNA Labs UAE, designed to assess the risk of a couple passing on beta thalassemia to their offspring. This test specifically analyzes the HBB gene, which is implicated in beta thalassemia, to identify any mutations that may be present.
For couples considering starting a family, this test provides invaluable insights into their genetic makeup and the potential risk of their children inheriting beta thalassemia. It involves collecting DNA samples from both partners, which are then analyzed in the laboratory for any mutations in the HBB gene.
In addition to the couple's analysis, the test also includes a prenatal trio analysis option, which can be performed during pregnancy to assess the fetus's risk of inheriting the condition. This is particularly important for couples identified as carriers of the beta thalassemia gene mutation, as it allows for early intervention and planning.
The cost of the "Beta Thalassemia-HBB Full Gene Analysis Couple and Prenatal Trio Analysis Test" at DNA Labs UAE is 3600 AED. Given the comprehensive nature of this test and the detailed insights it provides into genetic risk factors for beta thalassemia, it represents a crucial step for at-risk couples in planning for a healthy family.
